About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05394636

Cerebellar Superficial Siderosis in Cerebral Amyloid Angiopathy

Cerebellar superficial siderosis (SS) has been recently reported to be present in about 10% of both hereditary (n=50) and sporadic (n=46) cerebral amyloid angiopathy (CAA) patients on 3T MRI using sus...

Lead sponsor: Centre Hospitalier Universitaire de Nīmes•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Centre Hospitalier Universitaire de Nīmes

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•CAA patients (according to the modified Boston criteria)
•with acute symptoms related to acute ICH, acute subarachnoid haemorrhage, or cortical SS

Exclusion Criteria

•Patients with recent trauma,
•Patients with anticoagulation treatment,
•Patients with pathological blood coagulation tests (activated partial thromboplastin time \[aPTT\] ratio=patient's aPTT/normal control aPTT\] \>1.2; or partial thromboplastin time \[PTT\] \<75%) or platelet count (\<100 x 109/L)
•Patients with inflammatory CAA

Related studies

RECRUITINGPhase 2

A Study of AMDX-2011P in Participants With CAA

NCT05709314 · Cerebral Amyloid Angiopathy

Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System

NCT07098650 · Superficial Siderosis

RECRUITINGPhase 2

Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage

NCT07026994 · Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar

Prognosis of Cerebral Small Vessel Disease

NCT05734378 · Cerebral Amyloid Angiopathy, Small Vessel Cerebrovascular Disease, and more

Coach Pilot Study: Assessing Cognitive Function and Related Small Vessel Disease Markers After Intracerebral Hemorrhage

NCT05499169 · Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 4, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment111

Start dateJun 2022

Last updatedDec 4, 2025

Condition

Cerebral Amyloid Angiopathy Siderosis

Locations shown

CHU de Nîmes

Nîmes

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 4, 2025Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions